Search Results

Filter
  • 1-10 of  167,552 results for ""Tissue Plasminogen Activator""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Tissue plasminogen activator for acute branch atheromatous disease exhibits transient improvement and worsening.

  • Authors : Kobayashi Y; Department of Neurology, Ina Central Hospital, 1313-1, Ina, Nagano 396-8555, Japan; Department of Neurology, Nagano Municipal Hospital, 1333-1 Tomitake, Nagano 381-8551, Japan. Electronic address: .

Subjects: Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/therapeutic use ; Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/administration & dosage ; Fibrinolytic Agents*/Fibrinolytic Agents*/Fibrinolytic Agents*/therapeutic use

  • Source: Journal of the neurological sciences [J Neurol Sci] 2024 Oct 15; Vol. 465, pp. 123201. Date of Electronic Publication: 2024 Aug 30.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0375403 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Synergistic effects of neuroprotective drugs with intravenous recombinant tissue plasminogen activator in acute ischemic stroke: A Bayesian network meta-analysis.

  • Authors : Dang C; Department of Periodical Press/Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, China.; Wang Q

Subjects: Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/administration & dosage ; Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/therapeutic use ; Neuroprotective Agents*/Neuroprotective Agents*/Neuroprotective Agents*/administration & dosage

  • Source: PloS one [PLoS One] 2024 Dec 02; Vol. 19 (12), pp. e0311231. Date of Electronic Publication: 2024 Dec 02 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Tissue Plasminogen Activator or Perfluoropropane for Submacular Hemorrhage in Age-Related Macular Degeneration: A Factorial Randomized Clinical Trial.

  • Authors : Murphy GSP; King's Ophthalmology Research Unit, Ophthalmology Department, King's College Hospital, London, United Kingdom.; Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.

Subjects: Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/administration & dosage ; Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/therapeutic use ; Fluorocarbons*/Fluorocarbons*/Fluorocarbons*/administration & dosage

  • Source: JAMA ophthalmology [JAMA Ophthalmol] 2024 Dec 01; Vol. 142 (12), pp. 1157-1164.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589539 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Preparation and in vitro evaluation of tissue plasminogen activator-loaded nanoliposomes with anticoagulant coating.

  • Authors : Ahmaditabar P; Department of Biomedical Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran.; Mahmoodi M

Subjects: Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/chemistry ; Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/pharmacology ; Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/administration & dosage

  • Source: Biochimica et biophysica acta. General subjects [Biochim Biophys Acta Gen Subj] 2024 Nov; Vol. 1868 (11), pp. 130704. Date of Electronic Publication: 2024 Aug 22.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101731726 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Correlation between subretinal tissue plasminogen activator and air injection rates with pressure in a retina mimicking model.

  • Authors : Kim NH; Department of Ophthalmology, College of Medicine, Konkuk University, Konkuk University Medical Center, Seoul, 05030, Republic of Korea.; Lee M

Subjects: Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/administration & dosage ; Retina*/Retina*/Retina*/diagnostic imaging; Air/Air/Air/analysis

  • Source: Scientific reports [Sci Rep] 2024 Oct 31; Vol. 14 (1), pp. 26203. Date of Electronic Publication: 2024 Oct 31.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Early surgical displacement of submacular hemorrhage without tissue plasminogen activator use: one-year outcomes.

  • Authors : Abdulaal M; University of Texas Southwestern Medical Center, Dallas, TX.; Donkor R

Subjects: Visual Acuity*/Visual Acuity*/Visual Acuity*/physiology ; Retinal Hemorrhage*/Retinal Hemorrhage*/Retinal Hemorrhage*/diagnosis ; Retinal Hemorrhage*/Retinal Hemorrhage*/Retinal Hemorrhage*/physiopathology

  • Source: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie [Can J Ophthalmol] 2024 Oct; Vol. 59 (5), pp. e582-e589. Date of Electronic Publication: 2023 Nov 01.Publisher: Elsevier Country of Publication: England NLM ID: 0045312 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1715-3360

Record details

×
Academic Journal

Dual surface modification of polydimethylsiloxane (PDMS) with antithrombin-heparin complex (ATH) and tissue plasminogen activator (t-PA) for enhanced antithrombotic activity.

  • Authors : Li S; School of Biomedical Engineering, McMaster University, Hamilton, ON, Canada.; Atkinson HM

Subjects: Dimethylpolysiloxanes*/Dimethylpolysiloxanes*/Dimethylpolysiloxanes*/chemistry ; Heparin*/Heparin*/Heparin*/chemistry ; Heparin*/Heparin*/Heparin*/pharmacology

  • Source: Biomaterials advances [Biomater Adv] 2025 Jan; Vol. 166, pp. 214067. Date of Electronic Publication: 2024 Oct 10.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 9918383886206676 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Combined treatment of submacular hemorrhage with low-dose subretinal recombinant tissue plasminogen activator and intravitreal conbercept.

  • Authors : Ma Y; Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-fang Road, Wuhan, 430030, Hubei, China.; Rao S

Subjects: Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/administration & dosage ; Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/therapeutic use ; Retinal Hemorrhage*/Retinal Hemorrhage*/Retinal Hemorrhage*/drug therapy

  • Source: BMC ophthalmology [BMC Ophthalmol] 2024 Sep 05; Vol. 24 (1), pp. 395. Date of Electronic Publication: 2024 Sep 05.Publisher: BioMed Central Country of Publication: England NLM ID: 100967802 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2415

Record details

×
Academic Journal

Heterologous expression, purification and single step efficient refolding of recombinant tissue plasminogen activator (Reteplase) from E. coli.

  • Authors : Bhatt M; Gujarat Biotechnology Research Centre, Department of Science & Technology, MS Building, 6th Floor, GH Road, Sector - 11, Gandhinagar, Gujarat, 382011, India.; Masi HA

Subjects: Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/genetics ; Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/chemistry ; Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/isolation & purification

  • Source: Protein expression and purification [Protein Expr Purif] 2024 Sep; Vol. 221, pp. 106504. Date of Electronic Publication: 2024 May 22.Publisher: Academic Press Country of Publication: United States NLM ID: 9101496 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Delayed onset septic pelvic thrombophlebitis treated by tissue-plasminogen activator following initial treatment for massive right ovarian vein thrombosis and methicillin-resistant Staphylococcus aureus bacteremia: A case report.

  • Authors : Miyamori D; Department of General Internal Medicine, Hiroshima University Hospital, Hiroshima-shi, Hiroshima-ken, Japan.; Department of Emergency Medicine, JA Onomichi General Hospital, Onomichi, Hiroshima, Japan.

Subjects: Thrombophlebitis*/Thrombophlebitis*/Thrombophlebitis*/drug therapy ; Thrombophlebitis*/Thrombophlebitis*/Thrombophlebitis*/microbiology ; Methicillin-Resistant Staphylococcus aureus*/Methicillin-Resistant Staphylococcus aureus*/Methicillin-Resistant Staphylococcus aureus*/isolation & purification

  • Source: The journal of obstetrics and gynaecology research [J Obstet Gynaecol Res] 2024 Aug; Vol. 50 (8), pp. 1408-1414. Date of Electronic Publication: 2024 May 28.Publisher: Wiley on behalf of the Japan Society of Obstetrics and Gynecology] Country of Publication: Australia NLM ID: 9612761 Publication Model:

Record details

×
  • 1-10 of  167,552 results for ""Tissue Plasminogen Activator""